PROTAGONIST THERAPEUTICS
Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
PROTAGONIST THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
Brisbane, Queensland, Australia
Country:
Australia
Website Url:
http://www.protagonist-inc.com
Total Employee:
101+
Status:
Active
Contact:
61 7 3346 2975
Email Addresses:
[email protected]
Total Funding:
388.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics ReCAPTCHA
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Protagonist Therapeutics
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Protagonist Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Protagonist Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Protagonist Therapeutics
Adage Capital Management
Adage Capital Management investment in Series C - Protagonist Therapeutics
Canaan Partners
Canaan Partners investment in Series C - Protagonist Therapeutics
Pharmstandard International
Pharmstandard International investment in Series C - Protagonist Therapeutics
Starfish Ventures
Starfish Ventures investment in Series C - Protagonist Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Protagonist Therapeutics
Inbio Ventures
Inbio Ventures investment in Series C - Protagonist Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-28 | Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer |
Official Site Inspections
http://www.protagonist-inc.com Semrush global rank: 3.4 M Semrush visits lastest month: 4.6 K
- Host name: 104.26.14.156
- IP address: 104.26.14.156
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Protagonist Therapeutics"
Governance - Protagonist Therapeutics Inc.
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical …See details»
Corporate Presentation - protagonist-inc.com
Nov 18, 2024 How is Protagonist supporting diverse and equitable discovery and development? Protagonist actively works to ensure we have strong patient representation in our clinical …See details»
Protagonist Therapeutics - Crunchbase Company …
Contact Email [email protected] Phone Number 61 7 3346 2975 Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit …See details»
Protagonist Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Protagonist Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 26 clinical trials, 105 news, and 50 literature, Disease Domain:Endocrinology and …See details»
Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide …
Jan 31, 2024 Takeda Will Be Protagonist's Co-Development, U.S. Co-Commercialization Partner With 50:50 Profit Share, and With Exclusive Ex-U.S. Global Rights to Commercialize …See details»
Protagonist Therapeutics, Inc. - AnnualReports.com
Protagonist Therapeutics is a clinical stage biopharmaceutical company that utilizes a proprietary technology platform to discover and develop novel peptide-based therapeutics to address significant unmet medical needs and transform …See details»
PROTAGONIST THERAPEUTICS, INC. - AnnualReports.com
PROTAGONIST THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 98-0505495 (State or other jurisdiction of incorporation or organization) (I.R.S. …See details»
Company Protagonist Therapeutics, Inc. - MarketScreener.com
Nov 30, 2008 Protagonist Therapeutics, Inc. is a biopharmaceutical company. The Company uses its peptide-based chemical entities rusfertide and JNJ-2113 in different stages of …See details»
Protagonist Therapeutics - Products, Competitors, Financials, …
Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update. Nov 8, 2024. European Business Magazine November 7, 2024 1 Top line results for JNJ-2113 Phase …See details»
Areas of Focus - Protagonist Therapeutics Inc.
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing …See details»
Protagonist Appoints Sarah O'Dowd to Board of Directors - PR …
NEWARK, Calif., Aug. 13, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced the appointment of Sarah O'Dowd as an independent director to the …See details»
Protagonist and Parenthetic Announce Merger
Aug 15, 2023 “Protagonist’s use of artificial intelligence to understand public discourse and audience beliefs, paired with Parenthetic’s communication frameworks and methodologies, will …See details»
Protagonist - Crunchbase Company Profile & Funding
Protagonist closed its last funding round on Jan 14, 2022 from a Debt Financing round. Who are Protagonist 's competitors? Alternatives and possible competitors to Protagonist may include …See details»
Protagonist - Crunchbase Company Profile & Funding
Protagonist is the leading Narrative Analytics company, applying Machine Learning and Natural Language processing to big data to understand human mindsets at scale. The company …See details»
Protagonist - Company Profile - Tracxn
Oct 20, 2024 Protagonist ranks 121st among 297 active competitors. 23 of its competitors are funded while 44 have exited. Overall, Protagonist and its competitors have raised over $65.4M …See details»
CEO Dinesh Patel Talks Culture, Collaboration and Courage
How is Protagonist supporting diverse and equitable discovery and development? Protagonist actively works to ensure we have strong patient representation in our clinical studies. We …See details»
George Bousis - Protagonist
He's invested in over 85 companies and co-founded Protagonist, his latest venture. Beyond business, he enjoys gaming, music, real estate, and traveling. George's accolades include …See details»
Protagonist - Understand and influence your buyer's beliefs
Protagonist strengthens organizations by leveraging customer beliefs. - Create effective positioning and messaging informed by Narrative data - Understand how to improve an …See details»
Events & Presentations - Protagonist Therapeutics Inc.
May 13, 2024 Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new …See details»